HUP0000397A3 - The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation - Google Patents

The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation

Info

Publication number
HUP0000397A3
HUP0000397A3 HU0000397A HUP0000397A HUP0000397A3 HU P0000397 A3 HUP0000397 A3 HU P0000397A3 HU 0000397 A HU0000397 A HU 0000397A HU P0000397 A HUP0000397 A HU P0000397A HU P0000397 A3 HUP0000397 A3 HU P0000397A3
Authority
HU
Hungary
Prior art keywords
pasessing
glucocorticoid
substances
treatment
pharmaceutical composition
Prior art date
Application number
HU0000397A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of HUP0000397A2 publication Critical patent/HUP0000397A2/hu
Publication of HUP0000397A3 publication Critical patent/HUP0000397A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU0000397A 1996-12-20 1997-12-16 The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation HUP0000397A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9604751A SE9604751D0 (sv) 1996-12-20 1996-12-20 New therapy
PCT/SE1997/002124 WO1998027987A1 (en) 1996-12-20 1997-12-16 New treatment for joint inflammation

Publications (2)

Publication Number Publication Date
HUP0000397A2 HUP0000397A2 (hu) 2000-10-28
HUP0000397A3 true HUP0000397A3 (en) 2001-01-29

Family

ID=20405107

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000397A HUP0000397A3 (en) 1996-12-20 1997-12-16 The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation

Country Status (20)

Country Link
US (1) US6432937B1 (hu)
EP (1) EP0957922A1 (hu)
JP (1) JP2001507024A (hu)
KR (1) KR20000069594A (hu)
AU (1) AU5502598A (hu)
BR (1) BR9713975A (hu)
CA (1) CA2274769A1 (hu)
CZ (1) CZ219399A3 (hu)
EE (1) EE9900258A (hu)
HU (1) HUP0000397A3 (hu)
ID (1) ID21763A (hu)
IL (1) IL130485A0 (hu)
IS (1) IS5056A (hu)
NO (1) NO993066L (hu)
NZ (1) NZ336025A (hu)
PL (1) PL334012A1 (hu)
SE (1) SE9604751D0 (hu)
SK (1) SK82699A3 (hu)
TR (1) TR199901413T2 (hu)
WO (1) WO1998027987A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010510227A (ja) 2006-11-20 2010-04-02 プレジデント アンド フェロウズ オブ ハーバード カレッジ 痛みおよび痒みの治療方法、組成物およびキット
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
EP3485881B1 (en) 2009-07-10 2024-03-13 President and Fellows of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
UA112769C2 (uk) 2011-02-18 2016-10-25 Ендо Фармасьютікалз Інк. Аміноінданові сполуки і їх застосування при лікуванні болю
CA2853279C (en) 2011-10-24 2021-03-23 Endo Pharmaceuticals Inc. Cyclohexylamines
BR112016013734A2 (pt) 2013-12-16 2017-08-08 Asana Biosciences Llc Composto, composição farmacêutica, kit, e uso de um composto
MX2018001447A (es) 2015-08-03 2019-02-21 Harvard College Bloqueadores de canal de ion cargado y metodos para su uso.
JP2016193937A (ja) * 2016-08-09 2016-11-17 株式会社エヌ・エル・エー 関節痛緩和組成物および機能性食品、並びに発酵ショウガ及びその製造方法
RU2019112740A (ru) 2016-09-30 2020-11-02 АСАНА БАЙОСАЙЕНСИЗ, ЭлЭлСи P2x3 и/или p2x2/3 соединения и способы
WO2020185881A1 (en) 2019-03-11 2020-09-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2022527438A (ja) 2019-03-11 2022-06-02 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2023500891A (ja) 2019-11-06 2023-01-11 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
WO2021091586A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
CA2140660A1 (en) * 1993-06-13 1994-12-22 Uwe R. Juergens Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system

Also Published As

Publication number Publication date
CZ219399A3 (cs) 1999-09-15
ID21763A (id) 1999-07-22
AU5502598A (en) 1998-07-17
SE9604751D0 (sv) 1996-12-20
HUP0000397A2 (hu) 2000-10-28
NZ336025A (en) 2001-02-23
PL334012A1 (en) 2000-01-31
NO993066D0 (no) 1999-06-21
IL130485A0 (en) 2000-06-01
CA2274769A1 (en) 1998-07-02
SK82699A3 (en) 2000-02-14
EE9900258A (et) 1999-12-15
TR199901413T2 (xx) 1999-08-23
BR9713975A (pt) 2000-04-11
NO993066L (no) 1999-06-21
JP2001507024A (ja) 2001-05-29
IS5056A (is) 1999-05-27
WO1998027987A1 (en) 1998-07-02
EP0957922A1 (en) 1999-11-24
US6432937B1 (en) 2002-08-13
KR20000069594A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
HUP0000397A3 (en) The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
IL174082A0 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use for the preparation of a pharmaceutical composition
AU3265695A (en) Novel naphthyridine derivative and medicinal composition thereof
AU2109195A (en) Two-component device for the administration of drugs
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU2027695A (en) Pharmaceutical composition for treating stoma-peripheral inflammation diseases
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
IL125446A0 (en) Pharmaceutical composition for the treatment of asthma allergy and inflammation
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU2753095A (en) Triterpene derivative and medicinal composition
HUP0001486A3 (en) Pharmaceutical composition for topical use cantaining nimesulide gel systems and process for preparation thereof
AU7042796A (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
AU5103196A (en) Form of administration for applying pharmaceutical substances and auxiliary substances, and process for the preparation thereof
IL126539A0 (en) New pregnane derivatives with no alpha-17 substituent their medicinal use manufacturing method and their intermediates and related compounds
AU2587195A (en) Growth hormone therapy and related methods and pharmaceutical compositions
AU4137596A (en) Method for the treatment of periodontal disease and a pharmaceutical composition useful in said method
GB9518553D0 (en) New urea derivatives processes for the preparation thereof and pharmaceutical composition comprising the same
GB9606579D0 (en) Pharmaceutical composition and methods for the manufacture thereof
AU3567995A (en) Steroid esters and amides, method for their preparation and their pharmaceutical use
AUPN766496A0 (en) Method and composition for the potentiation of anti-inflammatory drugs
GB2296496B (en) Pharmaceutical pregnane derivatives
AU5844796A (en) Fused benzodiazepinone derivatives and medicinal composition of the same